CDV3 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.62989999999519E-07 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.63769999994567E-06 |
Normal-vs-Stage2 |
1.764420E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.737900E-02 |
Stage1-vs-Stage2 |
6.242000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
5.634400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
8.955000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.0036000004704E-07 |
Normal-vs-AfricanAmerican |
3.577300E-03 |
Normal-vs-Asian |
1.368030E-01 |
Caucasian-vs-AfricanAmerican |
9.121600E-01 |
Caucasian-vs-Asian |
3.668800E-01 |
AfricanAmerican-vs-Asian |
6.023000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.06709999999566E-05 |
Normal-vs-Female |
2.20289999997014E-06 |
Male-vs-Female |
9.554400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.370200E-02 |
Normal-vs-Extreme_Weight |
4.70239999994515E-06 |
Normal-vs-Obese |
3.279200E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.388200E-01 |
Normal_Weight-vs-Obese |
6.546600E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
8.954600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.246200E-04 |
Normal-vs-Age(41-60Yrs) |
5.044900E-04 |
Normal-vs-Age(61-80Yrs) |
1.95613999999233E-05 |
Normal-vs-Age(81-100Yrs) |
3.632700E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.102200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.080600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.179000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.979800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.422200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.384000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
6.975600E-02 |
Normal-vs-Grade 3 |
1.780190E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
3.186000E-01 |
Grade 2-vs-Grade 4 |
6.975600E-02 |
Grade 3-vs-Grade 4 |
1.780190E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.78479999954651E-07 |
Normal-vs-N1 |
4.14890000000057E-05 |
N0-vs-N1 |
3.724000E-01 |
|
|